DEBRA FOSTER: Open Payments
NPI 1700097532 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,135 in 55 payments from 18 companies in 2025. Trend: 2023 $947 · 2024 $995 · 2025 $1,135
Food & beverage: $1,135
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $154 |
| GlaxoSmithKline, LLC. | 6 | $114 |
| PFIZER INC. | 5 | $110 |
| ABBVIE INC. | 3 | $83 |
| Amgen Inc. | 5 | $83 |
| Astellas Pharma US Inc | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Novo Nordisk Inc | 4 | $75 |
| Lilly USA, LLC | 4 | $69 |
| Axsome Therapeutics, Inc. | 3 | $63 |
Products named: CAPLYTA, TRELEGY ELLIPTA, Veozah, EVENITY, QULIPTA, Ozempic, TZIELD, PAXLOVID.
Industry payments across TN — which companies pay providers there.
